The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1732
Addendum: Drugs for Open-Angle Glaucoma
Download PDF:   US English
Med Lett Drugs Ther. 2025 Jul 7;67(1732):112   doi:10.58347/tml.2025.1732e
Disclosures
Objective(s)
 Select a term to see related articles  diltiazem   drug safety   glaucoma   verapamil 

Our recent article on glaucoma stated that systemic adverse effects of ophthalmic beta blockers include bradycardia. A reader suggested we should have also mentioned that they rarely cause heart block, particularly in patients receiving other negative chronotropic drugs such as verapamil or diltiazem, and when that occurs, stopping the ophthalmic beta blocker may avoid insertion of a pacemaker.

© The Medical Letter, Inc. All Rights Reserved.
The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.
This article has been freely provided.
arrow to previous article